MicroStrategy (NasdaqGS:MSTR) is currently facing a legal battle with the announcement of a class action lawsuit by Pomerantz LLP, alleging misleading statements about its bitcoin-focused strategy.

Pfizer faces several headwinds, including patent cliffs, regulatory risks, and a setback in obesity drug development. Click ...

In 'Diet, Drugs, and Dopamine,' former FDA Commissioner David A. Kessler offers a comprehensive guide to weight loss.